Related Experiment Video
Updated: Jun 7, 2025

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.9K
Grading Melanocytic Dysplasia: Updated Histopathologic Criteria
Christopher R Shea1, Victor G Prieto2, Catherine M Shachaf3
1Section of Dermatology, The University of Chicago Medicine, Chicago, Illinois, USA.
Journal of Cutaneous Pathology
|November 12, 2024
Summary
This study refines the grading of melanocytic dysplasia, integrating the World Health Organisation Classification of Skin Tumours (WHO-C) with the Duke classification. Updated criteria offer more precise assessment of dysplastic nevi for dermatopathologists.
Area of Science:
- Dermatopathology
- Histopathology
- Oncology
Background:
- The World Health Organisation Classification of Skin Tumours (WHO-C) introduced a dichotomous grading system for dysplastic nevi (high-grade vs. low-grade).
- The Duke classification offers quantitative histopathologic criteria, emphasizing architectural features and cytology for assessing dysplastic nevi.
Purpose of the Study:
- To propose and illustrate updated criteria for scoring and grading melanocytic dysplasia.
- To refine existing classification systems for more precise assessment of dysplastic nevi.
Main Methods:
- Integration of WHO-C definitions and categories.
- Refinement of quantitative and architectural elements from the Duke grading system.
- Illustration of updated scoring and grading criteria for melanocytic dysplasia.
Main Results:
- Development of updated criteria for assessing melanocytic dysplasia.
- Facilitation of more detailed and precise evaluation of dysplastic nevi.
- A refined approach combining WHO-C and Duke classification elements.
Conclusions:
- The proposed updated criteria enhance the assessment of melanocytic dysplasia.
- This refined system aids dermatopathologists in accurately classifying dysplastic nevi.
- The updated approach provides a more nuanced understanding of melanocytic dysplasia.

